News & Events
November 3, 2021
WEBINAR | Biomarkers of Effect: Safety Biomarkers as Disease BiomarkersWhen: November 3, 2021 – 10 a.m. US ET C-Path’s Predictive Safety Testing Consortium (PSTC) invites you to this free webinar, the second in its 15th anniversary educational webinar series, to explore the use of safety biomarkers as disease and/or efficacy biomarkers. Pre-recorded presentations will provide an examples of safety biomarkers being explored as disease/efficacy biomarkers throughout Industry, the translational......
August 25, 2021
WEBINAR | Alternative Solutions in Safety AssessmentWhen: August 25, 2021, 10 – 11:30 a.m. ET C-Path’s Predictive Safety Testing Consortium (PSTC) invites you to this free webinar, the second in its 15th anniversary educational webinar series, to explore the use of alternative solutions in safety assessment in drug development, including microphysiological systems (MPS) and In Vitro models. Pre-recorded presentations will provide an overview......
May 26, 2021
PSTC 15-year Anniversary Webinar SeriesJoin scientists from PSTC member companies, health authorities and other key opinion leaders during the PSTC 15-year Anniversary Webinar Series where they will share information about collaborative cutting-edge science taking place within the consortium’s working groups and engage in discussion on the complexities and opportunities surrounding safety biomarkers and biomarker qualification. Each webinar in the......
March 31, 2021
View Now: 2021 PSTC Virtual Workshop—March 31, 2021The Predictive Safety Testing Consortium (PSTC) launched its 15th anniversary celebration with a virtual public workshop. Scientists and experts from the U.S. Food and Drug Administration (FDA), the pharmaceutical industry, academia, and Critical Path Institute (C-Path) discussed PSTC’s work in the regulatory space, its current efforts in researching fluid biomarkers as predictive tools of drug-induced......
September 9, 2019 - September 10, 2019
Solutions to Drug Development Challenges Workshop: Utilizing Quantitative Approaches, Data Sharing, and Novel BiomarkersTitle Presenter Presentation Link Introduction Dr. John-Michael Sauer (C-Path) Keynote Address Dr. Joseph Scheeren (C-Path) Welcoming Remarks Dr. Janet Woodcock (US FDA) Session 2: Benefits of DDT progression to regulatory acceptance Moderators: Dr. Inish O’Doherty (C-Path) and Dr. Ameeta Parekh (US FDA) 2.1 A perspective on the history and evolution of drug development......